Magna-Lab moves to NASDAQ's OTC board

Article

The stock of niche MRI developer Magna-Lab has been moved to NASDAQ's OTC Bulletin Board due tothe company's failure to meet minimum listing requirements onNASDAQ's Small-Cap exchange. Magna-Lab, of Hicksville, NY, hopesto return to the small-cap market

The stock of niche MRI developer Magna-Lab has been moved to NASDAQ's OTC Bulletin Board due tothe company's failure to meet minimum listing requirements onNASDAQ's Small-Cap exchange. Magna-Lab, of Hicksville, NY, hopesto return to the small-cap market after securing additional fundinglater this year, according to vice president John Haytaian.

Magna-Lab failed to meet NASDAQ's net worth requirement of$1 million for the small-cap market after a private equity placementfell through late last year and the company began using debt tofund operations (SCAN 12/14/94). NASDAQ made the decision to moveMagna-Lab's stock earlier this month. Ironically, Magna-Lab'sstock began moving upward after the move, Haytaian said.

Magna-Lab signed a letter of intent this month for a secondarypublic offering of $5 million to take place in the next two tothree months that will bring the company back into compliancewith NASDAQ requirements. The firm may also complete a privateequity placement by then, according to Haytaian.

The company has been rounding out its stable of distributionpartners for the Magna-SL 0.3-tesla scanner, which received Foodand Drug Administration clearance last year (SCAN 9/28/94). Magna-Labthis month signed an agreement with American Medical Concepts(AMCI) of Houston to distribute Magna-SL to the U.S. orthopedicmarket. The deal will complement an agreement with Beta-Numericsfor the fee-per-scan and mobile markets, as well as a deal withElscint for international sales that has not yet been finalized.

Magna-Lab this month completed the first installation of Magna-SLto MedCenter Imaging in San Antonio, TX. The installation tookonly two days, Haytaian said. Imaging services firm Health Imagesof Atlanta will be under contract by Magna-Lab to provide servicefor that unit, he said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.